Volume 8, Issue 4 (2022)                   Pharm Biomed Res 2022, 8(4): 323-332 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Samir D, Saadia S, Maroua L. Assessment of Hematological and Electrolytes Levels and Oxidative Stress Predictive Factors by Logistic Regression Analysis of Acute Ischemic Stroke Disease. Pharm Biomed Res 2022; 8 (4) :323-332
URL: http://pbr.mazums.ac.ir/article-1-469-en.html
1- Department of Cellular and Molecular Biology, Faculty of Natural Sciences and Life, University of El Oued, El-Oued, Algeria.
Full-Text [PDF 714 kb]   (598 Downloads)     |   Abstract (HTML)  (1035 Views)
Full-Text:   (651 Views)
Introduction
Ischemic stroke is a common disease that affects the blood vessels in the brain [1]. This disease is considered one of the most dangerous ailments that affect the nervous system all over the world [2]. The number of stroke patients is gradually increasing worldwide, with an estimated 5.71 million people with stroke in 2004. According to the World Health Organization (WHO), this number is expected to reach 7.8 million in 2030 [3]. The Magrebia region has reported varied epidemiological transitions among all Arab and North Africa from 1990 to 2017, there are 13.008,01 cases of ischemic stroke and 5.184,36 cases of hemorrhagic stroke in Algeria [4]. According to the last WHO data published in 2017 stroke deaths in Algeria reached 22.917 or 13.19% of total deaths. Many risk factors cause stroke, including gender, age, and genetic factors, and the daily habits and behaviors of individuals play a large role in the occurrence of the disease [5].
 In addition, many factors related to the lifestyle and way of life of individuals may play an important role in the etiology of this disease, including diet [6]. Some diseases may be a direct cause of stroke, including cardiovascular disease, obesity, diabetes, smoking, and dyslipidemia [7]. Several inflammatory markers identify and detect stroke, such as tumor necrosis factor (TNFα) and interleukin 6 (IL-6), as well as lipid markers, including low-density lipoprotein (LDL) and high-density lipoprotein (HDL), along with imaging features, especially in patients without external symptoms [8]. For stroke treatment, t-PA can be the only FDA-approved stroke drug but has a limited treatment time window of 4.5 hours [9]. 
On the other hand, oxidative stress may be considered a strong cause of stroke, as oxidative stress is an abnormal condition in the body that results from an increase in the production of oxidants compared to antioxidants [10]. Oxidative stress is generally considered an influential and direct cause of injury and several diseases [11], including acute stroke [12]. The main cause of exacerbation of brain injury due to cerebral ischemia is the abnormal increase in oxygen free radicals, and the enhancement of oxygen free radical reactions is an important cause of cerebral edema secondary to CH [13]. Faced with these data, this study aimed to evaluate some biological parameters and the sensitivity and specificity of oxidative stress markers in men with ischemic stroke in the Touggourt (Algeria) region. 

Materials and Methods
Subjects 
Ethical approval was obtained from the ethics committee (15 EC/DCMB/FNSL/EU2019) of the Department of Cellular and Molecular Biology, Faculty of Natural Sciences and Life, University of El Oued. The study was done on 40 voluntary males divided into healthy reserved as controls with an average age of 56.13±3.32 years and ischemic stroke patients with an average age of 57.75±4.01 years. All of the volunteers (control and patients) in this study were living in the Touggourt area located in the South East of Algeria. 
Inclusion and exclusion criteria 
Ischemic stroke patients were selected based on clinical diagnosis by specialist doctors who confirmed stroke suffering for at least one month. In addition, patients had not received treatment for other types of chronic diseases for 30 days. Controls were healthy people not suffering from chronic or acute diseases and had not consumed drugs for 30 days. All other types of diseases were excluded. 
Sample collection and analyses
Blood sampling was done for both groups in the morning and fasting. It was performed using the vein at the end of the elbow. Blood samples were collected in three tubes. Dry tubes were centrifuged at 3000 rpm for 10 minutes, then the serum was obtained to achieve the dosage of blood glucose, electrolytes, and oxidative stress (malondialdehyde (MDA), glutathione (GSH), vitamin C, superoxide dismutase (SOD), oxygen radical absorbance capacity (ORAC), and total thiol parameters. The anticoagulant tube (EDTA) was mixed well and then the hematological and oxidative stress (MDA and GSH) parameters were assayed. Hematological analysis (FNS) was performed by the hematology auto analyzer. Determination of electrolytes (potassium, sodium, and chlorine) was done by an automatic electrolyte analyzer (Easylute). 
Preparation of erythrocyte and leukocyte homogenate
Blood EDTA tube contents were centrifuged at 2000 rpm for 10 minutes and the plasma was removed. The cap of the EDTA tube was lyzed with 50 mL of TBS buffer (EDTA 2.92M; tris 1.21M; pH=7) and incubated for 30 minutes in the freezer. After incubation, centrifugation was done at 2500 rpm for 10 minutes and the supernatant was obtained. Erythrocyte homogenate [14] was used for the determination of antioxidant activity [15]. After removing the plasma and separating of erythrocyte, the rest of the EDTA tube contents were centrifuged at 2000 rpm for 10 minutes. The pellet was washed with lysis buffer and shaken followed by incubation in the freezer for 30 minutes. After incubation, centrifugation was done at 2500 rpm for 10 minutes followed by washing with lysis buffer until the leukocyte pairing, followed by recovering to make the dosage of stress tests [15].
Measurement of oxidative markers 
The method of MD assay was based on the reaction between the carbonyl compounds of malondialdehyde with thiobarbituric acid according to the method of Yagi (1976) [16]. The level of reduced GSH was determined according to Weak and Cory (1988) [17] by measuring the optical density results from the formation of 2-nitro-5-mercapturic acid from the reduction of dithiol-bis-2-nitrobenzoic acid, which is called Ellman reagent with SH groups exist in GSH. SOD activity was assessed using the NBT by the superoxide anion (O2-) and was based on detecting the presence of SOD by measuring the absorbance at 560 nm [18]. The total antioxidant power (ORAC) and total thiol of the serum were estimated according to the method of Oyaizu (1986) [19] and Ellman [20], respectively. The plasma vitamin C was measured according to the method of Jacota and Dani (1982) [21] using the Folin reagent and a range of ascorbic acids.
Statistical analysis 
Statistical analysis was performed by SPSS software, version 20.0 software and comparisons were carried out by the Student t-test. Correlation analysis was carried out using the Pearson Correlation coefficient and regression analysis was used for other analyses. Differences were considered statically significant at P<0.05.
Results
Description of the study population 
The general data on the socioeconomic characteristics of the two groups of subjects included age, body weight, BMI, and blood pressure levels. These indicators did not have any statistically significant (P>0.05) differences but blood pressure increased in male stroke patients compared to controls as shown in Table 1.



Hematological and biochemical markers 
Our results (Table 2) showed that the leukocyte lineage (WBC and NEUT) significantly increased (P<0.001 and P<0.01, respectively) in the stroke group than the control group. Erythrocytes (hemoglobin and RBC) significantly decreased (P<0.001) in stroke men compared to the controls. But lymphocytes and PLT showed no significant differences (P>0.05). The result of blood glucose and blood electrolyte analysis (Table 2) showed that blood glucose levels significantly increased (P>0.05) while sodium, potassium, and chloride concentrations significantly decreased (P<0.05) in the stroke group to the control group. On the other hand, a significant decrease (P<0.01) in alkaline phosphatase activity was found in the stroke group than in the control group.



Oxidative stress markers
The analysis of blood oxidative stress parameters in control and stroke patients is shown in Table 3. There was a significant increase in MDA levels and SOD activity in erythrocytes (P<0.001), leukocytes (P<0.01) and in serum (P<0.05) and total antioxidant capacity (TAC) (P<0.01) in stroke group compared to male control subjects, in contrast there was a significant decrease  in leukocyte GSH (P<0.05) and serum GSH (P<0.05) and total thiol (P<0.01) levels of the male stroke patients compared to the male control subjects. However, our results showed no significant differences in erythrocyte, GSH, and serum vitamin C levels.



Predictive factors 
We found that erythrocyte MDA and leukocyte SOD were a significant predictive factors for stroke in men (P<0.05) with a high percentage of specificity (100; 100%) (AUC value: 1; 0.83) and sensitivity (40; 60 %), respectively (Table 4 and Figure 1).






 
On the other hand, our results showed that serum MDA, leukocyte GSH, and serum SOD levels were not significant predictive factors for stroke (P>0.05).
Discussion
The obtained results showed a significant increase in blood glucose levels in the stroke group compared to the control group. This result is in agreement with that of Xue et al. [22]. Hyperglycemia in acute stroke is probably the result of multiple factors, including cytokine-induced resistance to insulin action [23]. In our study, stroke patients had significantly low serum sodium, potassium, and chlorine levels compared to controls. Disorders of sodium and potassium concentration are the commonest electrolyte abnormalities found in the cerebral vascular accident (CVA) [24]. Low sodium after stroke results from either the syndrome of inappropriate antidiuretic hormone secretion, inappropriate fluid intake and fluid loss, or a high level of brain natriuretic peptides (BNPs) [25]. 
In our experimental study, the result showed a significant decrease in alkaline phosphatase (ALP) activity in both men and women patients as controls. This can be related to inflammation and oxidative stress after stroke [26]. Blood analyzes of stroke patients showed a clear increase in WBC and NEUT rates, which is consistent with a study by Laridan et al. [27] where their results found that levels of WBC in stroke are significantly elevated, as they are the 1st cell to be recruited after a stroke in the affected area leading to the increased expression of adhesion molecules, cytokines/chemokines, proteases, and reactive oxygen species [28]. Moreover, our results indicated that there was a significant decrease in RBC and HGB counts in men with stroke compared to healthy individuals, which is in agreement with the study by Santos-Silva et al. [29]. During ischemic stroke, inflammation can reduce the survival rate of RBC [30] by WBC activation post-stroke, which also leads to induced hemoglobin oxidation and lipid peroxidation, resulting in hemolysis and a decrease in erythrocyte count and hemoglobin levels [31]. 
In our experimental study, our results show that the MDA level is significantly increased in men with stroke compared to controls. This result is in agreement with the study by Antonio et al. [32] who explained that the MDA showed higher levels in stroke patients than in controls at hospital admission and its levels did not change in the following seven days. Stroke is accompanied by increased formation of free radicals [33]. The brain is particularly sensitive to oxidative injury because of the high content of polyunsaturated fatty acids [34]. Oxidative stress is an abnormal condition caused by an excess production of oxidants compared to the antioxidant [35], it has been considered the main cause of several pathologies [36]. 
In our experimental study, the results showed a significant decrease in GSH and total thiol levels both in female and male patients compared to controls. This result is in harmony with that of Zimmermann et al. [37] who stated that nearly two-thirds of patients with stroke showed decreased GSH levels. GSH is a sulfhydryl-containing tripeptide (Glu-Cys-Gly). It acts as an antioxidant and detoxifier [38]. As a consequence of post-stroke inflammation, tissue GSH is rapidly consumed and depleted. GSH is required for the synthesis of LTC4 from leukotriene A4 (LTA4; a pro-inflammatory lipid mediator) [39]. Concerning total thiol levels, our results are in agreement with the study by Işık et al. [40], who showed a significant decrease in serum total thiol levels in ischemic patients compared to the control groups. The subsequent decrease in plasma GSH levels was previously demonstrated both in an experimental model of cerebral ischemia and in clinical studies on acute stroke [41, 42]. Thus, the reduction of GSH levels contributes to the reduction of total thiol levels. SOD is known as one of the major enzymatic (oxidoreductases) defenses against ROS production [43]. 
Our experimental study demonstrated a significant increase in SOD activity in patients with stroke compared to controls, which is in agreement with the study by Abdullah et al. [44] who observed that during the acute phase, the MDA and SOD levels were increased in the serum of the patients with ischemic stroke. ORAC method is used to measure antioxidant capacity versus oxygen free radicals [45]. In our study, the serum TAC increased in ischemic stroke patients than in controls Lorente et al. [46] reported similar results to ours regarding higher levels of TAC in their ischemic stroke patients. The TAC up-regulation in patients with ischemic stroke might be a compensatory mechanism for higher ROS production in response to ischemia [46]. 
Conclusion
This study indicated that hematological parameters changed and oxidative stress was associated with the ischemic stroke disease as a cause or as a development factor for it and through the ROC analysis results where MDA, SOD, and TAC are considered to be the most important markers, which contributes to their early detection in the stroke diseases.
Ethical Considerations
Compliance with ethical guidelines

All human studies were approved by the appropriate ethics committee. All subjects gave their informed consent prior to their inclusion in the study.
Funding
This work was supported by the research project D01N01UN390120190001 funded by the Ministry of Higher Education, Algeria, and by the Directorate General for Scientific Research and Technological Development.
Authors' contributions
All authors equally contributed to preparing this article.
Conflict of interest
The authors declared that they have no conflicts of interest


References
  1. Maroua L, Saadia S, Samir D. Epidemiological Study of Stroke patients admitted to hospitals in Touggourt, Algeria. Int Res J Biological Sci. 2020; 9(2):12-8. [Link]
  2. Azarpazhooh MR, Mandzia JL, Thrift AG, Sposato LA, Morovatdar N, Amiri A, et al. Age, sex, and setting in the etiology of stroke study (ASSESS): Study design and protocol. J Neurol Sci. 2019; 399:209-13. [DOI:10.1016/j.jns.2019.02.024] [PMID]
  3. Marinkovic SP, Badlani G. Voiding and sexual dysfunction after cerebrovascular accidents. J Urol. 2001; 165(2):359-70. [DOI:10.1097/00005392-200102000-00003] [PMID]
  4. Zaidi Z, Boussouf K, Benkobbi S, Bitat-Aouati C, Boudiaf SB, Kaddour F, et al. Burden of cardiovascular diseases in the Maghrebian region, 1990-2017: Finding from the global burden diseases study 1990-2017. Health Sci J. 2019; 13(1):362. [DOI:10.21767/1791-809X.1000632]
  5. Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res. 2017; 120(3):472-95. [DOI:10.1161/CIRCRESAHA.116.308398] [PMID] [PMCID]
  6. Derouiche S, Atoussi N, Guediri S. The study of socioeconomic and clinic risk factors of breast cancer in Algerian women population. Front Biomed Technol. 2018; 5(3-4):51-7. [Link]
  7. Oliveira DMG, Aguiar LT, de Oliveira Limones MV, Gomes AG, da Silva LC, de Morais Faria CDC, et al. Aerobic training efficacy in inflammation, neurotrophies, and function in chronic stroke persons: A randomized controlled trial protocol. J Stroke Cerebrovasc Dis. 2019; 28(2):418-24. [DOI:10.1016/j.jstrokecerebrovasdis.2018.10.016] [PMID]
  8. Martinez E, Martorell J, Riambau V. Review of serum biomarkers in carotid atherosclerosis. J Vasc Surg. 2020; 71(1):329-41. [DOI:10.1016/j.jvs.2019.04.488] [PMID]
  9. Chen H, He Y, Chen S, Qi S, Shen J. Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology. Pharmacol Res. 2020; 158:104877. [DOI:10.1016/j.phrs.2020.104877] [PMID]
  10. Kaouachi A, Derouiche S. Phytochemical analysis, DPPH antioxidant activity and Acute toxicity of bark aqueous extracts of Pinus halepensis. Res J Chem Env Sci. 2018; 6(3):86-91. [Link]
  11. Derouiche S. Current review on herbal pharmaceutical improve immune responses against covid-19 infection. Res J Pharm Dosage Forms Tech. 2020; 12(3):181-4. [DOI:10.5958/0975-4377.2020.00031.2]
  12. Žitňanová I, Šiarnik P, Füllöp M, Oravec S, Penesová A, Ďuračková Z, et al. Gender differences in LDL- and HDL-cholesterol sub fractions in patients after the acute ischemic stroke and their association with oxidative stress markers. J Clin Biochem Nutr. 2018; 63(2):144-8. [DOI:10.3164/jcbn.17-105] [PMID] [PMCID]
  13. Zheng M, Wang X, Yang J, Ma S, Wei Y, Liu S. Changes of complement and oxidative stress parameters in patients with acute cerebral infarction or cerebral hemorrhage and the clinical significance. Exp Ther Med. 2019; 19:703-9. [DOI:10.3892/etm.2019.8229] [PMID] [PMCID]
  14. Samir D, Naouel A, Safa G. Assessment of hematological parameters, enzymes activities, and oxidative stress markers in salivary and blood of Algerian breast cancer patients receiving chemotherapy. J Biochem Tech. 2019; 10(4):50-8. [Link]
  15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. [DOI:10.1093/nar/16.3.1215] [PMID] [PMCID]
  16. Yagi K. Simple fluorometric assay for lipoperoxyde in blood plasma. Biochem Med. 1976; 15(2):212-6. [DOI:10.1016/0006-2944(76)90049-1]
  17. Weakbeker G, Cory JG. Ribonucleotide reductase activity and growth of glutathione-depled mous leihemia L1210 cells in vitro. Cancer Lett. 1988; 40(3):257-64. [DOI:10.1016/0304-3835(88)90084-5]
  18. Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971; 44(1):276-87. [DOI:10.1016/0003-2697(71)90370-8]
  19. Oyaizu M. [Studies on product of browning reaction prepared from glucosamine (Japanese)]. Jap J Nutr. 1986; 44(6):307-15. [DOI:10.5264/eiyogakuzashi.44.307]
  20. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82(1):70-7. [DOI:10.1016/0003-9861(59)90090-6]
  21. Jacota SK, Dani HM. A new colorimetric technique for the estimation of vitamin c, using folin phenol reagent. Anal Biochem. 1982; 127(1):178-82. [DOI:10.1016/0003-2697(82)90162-2]
  22. Chen R, Ovbiagele B, Feng W. Diabetes and stroke: Epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci. 2016; 351(4):380-6. [DOI:10.1016/j.amjms.2016.01.011] [PMID] [PMCID]
  23. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: A mechanistic justification for a trial of insulin infusion therapy. Stroke. 2006; 37(1):267-73. [DOI:10.1161/01.STR.0000195175.29487.30] [PMID]
  24. Pin-On P, Saringkarinkul A, Punjasawadwong Y, Kacha S, Wilairat D. Serum electrolyte imbalance and prognostic factors of postoperative death in adult traumatic brain injury patients: A prospective cohort study. Medicine. 2018; 97(45):e13081. [DOI:10.1097/MD.0000000000013081] [PMID] [PMCID]
  25. Hassan AR, Aryan ZA. Electrolyte disturbance in hemorrhagic and non-hemorrhagic stroke patients in Al-Diwaniyah teaching hospital. Asian J Pharm Clin Res. 2018; 11(11):456-9. [DOI:10.22159/ajpcr.2018.v11i11.29173]
  26. Tan G, Yuan R, Hao Z, Lei C, Xiong Y, Xu M, et al. Liver function indicators performed better to eliminate cardio embolic stroke than to identify it from stroke subtypes. J Stroke Cerebrovasc Dis. 2017; 26(1):230-6. [DOI:10.1016/j.jstrokecerebrovasdis.2016.09.032] [PMID]
  27. Laridan E, Denorme F, Desender L, François O, Andersson T, Deckmyn H, et al. Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol. 2017; 82(2):223-32. [DOI:10.1002/ana.24993] [PMID]
  28. Liu H, Wang R, Shi J, Zhang Y, Huang Z, You S, et al. Baseline neutrophil counts and neutrophil ratio may predict a poor clinical outcome in minor stroke patients with intravenous thrombolysis. J Stroke Cerebrovasc Dis. 2019; 28(11):1-7. [DOI:10.1016/j.jstrokecerebrovasdis.2019.104340]
  29. Santos-Silva A, Rebelo I, Castro E, Belo L, Catarino C, Monteiro I, et al. Erythrocyte damage and leukocyte activation in ischemic stroke. Clin Chim Acta. 2002; 320(1-2):29-35. [DOI:10.1016/S0009-8981(02)00039-6]
  30. Dabrowska S, Andrzejewska A, Lukomska B, Janowski M. Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J Neuroinflammation. 2019; 16(1):178. [DOI:10.1186/s12974-019-1571-8] [PMID] [PMCID]
  31. Bateman RM, Sharpe MD, Singer M, Ellis CG. The effect of sepsis on the erythrocyte. Int J Mol Sci. 2017; 18(9):1932. [DOI:10.3390/ijms18091932] [PMID] [PMCID]
  32. Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med. 2005; 39(7):841-52. [DOI:10.1016/j.freeradbiomed.2005.06.025] [PMID]
  33. Cherubini A, Polidori MC, Bregnocchi M, Pezzuto S, Cecchetti R, Ingegni T, et al. Antioxidant profile and early outcome in stroke patients. Stroke. 2000; 31(10):2295-300. [DOI:10.1161/01.STR.31.10.2295] [PMID]
  34. Menon B, Ramalingam K, Kumar R. Evaluating the role of oxidative stress in acute ischemic stroke. J Neurosci Rural Pract. 2020; 11(1):156-9. [DOI:10.1055/s-0039-3402675] [PMID] [PMCID]
  35. Samir D, Kaouther A, Manal D. Polysaccharides and ascorbic acid content and the effect of aqueous extract of portulaca oleracea in high-fat diet-induced obesity, dyslipidemia and liver damage in albino wistar rats. Algerian J arid envir. 2017; 7(2):16-26. [DOI:10.12816/0046095]
  36. Derouiche S, Degachi O, Gharbi K. The effect of purslane and aquilaria malaccensis on insulin-resistance and lipid peroxidation in high-fructose diet rats. Rom J Diabetes Nutr Metab Dis. 2020; 27(4):357-65. [Link]
  37. Zimmermann C, Winnefeld K, Streck S, Roskos M, Haberl RL. Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol. 2004; 51(3):157-61. DOI:10.1159/000077662] [PMID]
  38. Ozkul A, Akyol A, Yenisey C, Arpaci E, Kiylioglu N, Tataroglu C. Oxidative stress in acute ischemic stroke. J Clin Neurosci. 2007; 14(11):1062-6. [DOI:10.1016/j.jocn.2006.11.008] [PMID]
  39. Chan SJ, Ng MPE, Zhao H, Ng GJL, De Foo C, Wong PTH, et al. Early and sustained increases in leukotriene b4 levels are associated with poor clinical outcome in ischemic stroke patients. J Neurothera. 2019; 17:282-93. [DOI:10.1007/s13311-019-00787-4] [PMID] [PMCID]
  40. Işık M, Beydemir Ş, Yılmaz A, Naldan ME, Aslan HE, Gülçin İ. Oxidative stress and mRNA expression of acetylcholinesterase in the leukocytes of ischemic patients. Biomed. Pharmacother. 2017; 87:561-7. [DOI:10.1016/j.biopha.2017.01.003] [PMID]
  41. Maksimova MY, Ivanov AV, Virus ED, Alexandrinv VV, Nikiforova KA, Bulgakova PO, et al. Disturbance of thiol/disulfide aminothiols homeostasis in patients with acute ischemic stroke stroke: Preliminary findings. Clin Neurol Neurosurg. 2019; 183:105393. [DOI:10.1016/j.clineuro.2019.105393] [PMID]
  42. Bektas H, Vural G, Gumusyayla S, Deniz O, Alisik M, Erel O. Dynamic thiol-disulfide homeostasis in acute ischemic stroke patients. Acta Neurol Belg. 2016; 116(4):489-94. [DOI:10.1007/s13760-016-0598-1] [PMID]
  43. Pascotini MET, Flores DAE, Kegler MA, Konzen MV, Fornari MAL, Arend MJ, et al. Brain-derived neurotrophic factor levels are lower in chronic stroke patients: A relation with manganese-dependent superoxide dismutase ALA16VAL single nucleotide polymorphism through tumor necrosis factor-α and caspases pathways. J Stroke Cerebrovasc Dis. 2018; 27(11):3020-9. [DOI:10.1016/j.jstrokecerebrovasdis.2018.06.032] [PMID]
  44. Abdullah A, Ssefer V, Ertugrul U, Osman E, Esref A, Ugur CM, et al. Evaluation of serum oxidant/antioxidant balance in patients with acute stroke. J Pak Med Assoc 2013; 63(5):590-2. [PMID]
  45. Wesołowski P, Zawada K, Wojtowicz A, Strużycka I, Kamiński T. Assessment of salivary total antioxidant capacity in patients with primary untreated head and neck squamous cell carcinoma with ORAC. J Oral Pathol Med. 2016; 45(10):753-7. [DOI:10.1111/jop.12433] [PMID]
  46. Shaafi S, Hadisi F, Mahmoudinezhad M, Razmi H, Nejadghaderi SA, Khalili M. The significance of the oxidative stress markers in the one-year prognosis of patients with acute ischemic stroke: A case-control study. BMC Neurol. 2021; 21(1):258. [DOI:10.1186/s12883-021-02257-x] [PMID] [PMCID]
Type of Study: Original Research | Subject: Hematology and Oncology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb